Press Releases Amgen Inc.

Equities

AMGN

US0311621009

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
305 ^USD	-0.22%		-0.27%	+5.90%

Jun. 07	AbbVie's tight grip on Humira market raises concerns about biosimilars	RE
Jun. 06	Transcript : Amgen Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-06-2024 09:00 AM

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AMGEN ANNOUNCES POSITIVE RESULTS FOR PHASE 3 REGISTRATIONAL TRIAL EVALUATING UPLIZNA FOR TREATMENT OF IMMUNOGLOBULIN G4-RELATED DISEASE	Jun. 06	AQ
AMGEN TO PRESENT AT GOLDMAN SACHS 45TH ANNUAL GLOBAL HEALTHCARE CONFERENCE	Jun. 05	PR
AMGEN ANNOUNCES POSITIVE RESULTS FOR PHASE 3 REGISTRATIONAL TRIAL EVALUATING UPLIZNA® (INEBILIZUMAB-CDON) FOR TREATMENT OF IMMUNOGLOBULIN G4-RELATED DISEASE (IgG4-RD)	Jun. 05	PR
AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE	Jun. 03	PR
Amgen : 2024 Annual Meeting of Stockholders Presentation	May. 31	PU
Supreme Court Holds Invalid Cholesterol Drug Patent That Covered Millions Of Undisclosed Antibodies	May. 27	AQ
Amgen : An Underrecognized Risk Factor for Heart Disease	May. 23	PU
Improving treatment responses to solid tumours with trispecific TCEs	May. 23	AQ
Amgen : From the Office to the Lab, Amgen Uses AI Tools to Unlock Innovation	May. 22	PU
Amgen : Actress and Producer Gina Torres Urges Hispanic Americans to Prioritize Cholesterol Care	May. 21	PU
Amgen : At Milken Global Conference, Bradway Calls for Protecting U.S. Policy Ecosystem That Fosters Innovation	May. 20	PU
Driving Long-Term Growth: IMDELLTRA™ Approval and Information Update Presentation	May. 20	PU
Astrazeneca - New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease	May. 20	AQ
AMGEN - NEW DATA PRESENTED AT ATS 2024 SHOW THE POTENTIAL OF TEZSPIRE TO HELP PATIENTS LIVING WITH COPD	May. 20	AQ
Amgen And Sandoz Settle Denosumab BPCIA Litigation	May. 20	AQ
Amgen : Expanding Innovation in BiTE® Technology for Patients with Extensive Stage Small Cell Lung Cancer (ES SCLC)	May. 16	PU
Court Cancels Injunction Hearings In Aflibercept BPCIA Litigation; Regeneron May Seek Temporary Restraining Orders	May. 16	AQ
Amgen : Trusting Your Gut	May. 15	PU
Understanding Product-By-Process Claims In Patent Law	May. 14	AQ
Enabling The "Full Scope" Of Claims In View Of The Supreme Court's Decision In Amgen	May. 13	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Amgen Inc.

Equities

AMGN

US0311621009

Press Releases

Filters